EZH2 and colonic neoplasm: Such interpretation is further supported by our assays showing that B32B3 treatment is ineffective at impairing cancer cell growth and H3K27me3 after ectopic expression of EZH2T367D phospho-mimicking mutant in EZH2-depleted colon cancer cells (Fig. 5a).